D. E. Shaw & Co., Inc. A Tyr Pharma Inc Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 15,286 shares of LIFE stock, worth $28,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,286Holding current value
$28,431% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding LIFE
# of Institutions
116Shares Held
50MCall Options Held
684KPut Options Held
468K-
Federated Hermes, Inc. Pittsburgh, PA14.7MShares$27.3 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.66MShares$8.66 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY3.82MShares$7.11 Million2.7% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA2.1MShares$3.9 Million0.0% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...